Litigation Details for Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited (D. Mass. 2022)
✉ Email this page to a colleague
Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited (D. Mass. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-09-20 |
| Court | District Court, D. Massachusetts | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gaylore Stearns |
| Jury Demand | None | Referred To | |
| Parties | RADIUS HEALTH, INC. | ||
| Patents | 8,148,333; 8,748,382 | ||
| Attorneys | Daniel E. Orr | ||
| Firms | Windels, Marx, Lane & Mittendorf, LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited (D. Mass. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2024-08-16 | 149 | Summary Judgment | Infringement of U.S. Patent Nos. 10,996,208 and 8,148,333 and no invalidity under § 112 of U.S. Patent Nos. 10,996,208…10,996,208, 11,782,041 and 8,148,333 by Ipsen Pharma S.A.S., Radius Health, Inc.. (McManus, Caetlin) (Entered… 20 September 2022 1:22-cv-11546 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2024-09-16 | 164 | ofInfringement of U.S. Patent Nos. 10,996,208 and 8,148,333 and NoInvalidity Under § 112 of U.S. Patent Nos. 10,996,208…10,996,208, 11,782,041 and 8,148,333 filed by Orbicular Pharmaceutical Technologies Private Limited. (McManus… 20 September 2022 1:22-cv-11546 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| 2023-08-04 | 42 | Memorandum & Order | infringing United States Patent Nos. RE49,444 (the ’444 patent), 8,148,333 (the ’333 patent), 8,748,382 (the …the ’382 patent), and 10,996,208 (the ’208 patent). Before the court are the parties’ briefs on claim …related patents, the court is not persuaded. Nothing within the cited language from U.S. Patent No. 7,…August 1, 2023. THE PATENTS Abaloparatide is a parathyroid hormone-related…bone mass and quality. The ’333, ’382, and ’444 patents Case 1:22-cv-11546-RGS Document 42 Filed | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
